Pharmacokinetic outcomes
Pharmacokinetic data were available from 11 patients. Two patients discontinued treatment prior to the PK sampling day (Week 6 Day 1), and no PK data were available for those patients. Steady-state plasma concentration versus time profiles for venetoclax and ibrutinib are provided in the data supplement (Supplemental Fig. 